<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04010214</url>
  </required_header>
  <id_info>
    <org_study_id>MRCTA,ECFAH of FMU[2019]195</org_study_id>
    <nct_id>NCT04010214</nct_id>
  </id_info>
  <brief_title>A Registered Cohort Study on Cerebellar Ataxia</brief_title>
  <official_title>A Registered Cohort Study on Cerebellar Ataxia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ning Wang, MD., PhD.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Fujian Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cerebellar ataxia is a form of ataxia originating in the cerebellum. Cerebellar ataxia can
      occur as a result of many diseases and may present with symptoms of an inability to
      coordinate balance, gait, extremity and eye movements. To understand the clinical and genetic
      characteristics of cerebellar ataxia, we establish a registered cohort to follow up Chinese
      patients with cerebellar ataxia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">December 2059</completion_date>
  <primary_completion_date type="Anticipated">December 2039</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of hereditary cerebellar ataxia</measure>
    <time_frame>Up to 20years</time_frame>
    <description>Look for the causative gene in the patient with cerebellar ataxia</description>
  </primary_outcome>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Cerebellar Ataxia</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with cerebellar ataxia who are diagnosed in the First Affiliated Hospital of
        Fujian Medical University by tow neurologists.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with cerebellar ataxia based on the diagnoses of tow neurologists

          -  Relatives of patients with cerebellar ataxia

          -  Unrelated healthy controls

          -  Participants or legal guardian(s) willing and able to complete the informed consent
             process

        Exclusion Criteria:

          -  Participants are unable to comply with trial procedures and visit schedule
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shi-Rui Gan, MD.Phd</last_name>
    <phone>+8613850172725</phone>
    <email>ganshirui@fjmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yi Lin, MD.Phd</last_name>
    <phone>+8613615039153</phone>
    <email>linyi7811@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Neurology ,First Affiliated Hospital Fujian Medical University</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350005</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>July 4, 2019</study_first_submitted>
  <study_first_submitted_qc>July 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2019</study_first_posted>
  <last_update_submitted>September 19, 2019</last_update_submitted>
  <last_update_submitted_qc>September 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital of Fujian Medical University</investigator_affiliation>
    <investigator_full_name>Ning Wang, MD., PhD.</investigator_full_name>
    <investigator_title>The Vice President</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ataxia</mesh_term>
    <mesh_term>Cerebellar Ataxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

